SCHEMBL2863264

SCHEMBL2863264

CCc1ccc([O])c(CC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.44
CYP2A6 P11509 2/20 0.43
CYP1A2 P05177 1/20 0.43
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
BACE1 P56817 1/20 0.39
CA2 P00918 1/20 0.37
AKT1 P31749 1/20 0.37
TP53 P04637 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
KIF11 P52732 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10634220 0.82 ALDH1A1 (0.37) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL8392278 0.81 GABRA1 (0.53) ALDH1A1LMNAMAPTSMN1; SMN2HPGD
SCHEMBL2862097 0.80 TRPA1 (0.44) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL444673 0.79 TRPA1 (0.48) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL7567988 0.79 ALDH1A1 (0.46) CYP1A2ALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3169916 0.78 CYP1A2 (0.46) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL10415499 0.78 KAT8 (0.49) ALDH1A1LMNATP53LPLLIPG
SCHEMBL14764389 0.76 TRPA1 (0.64) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL5050079 0.75 TRPA1 (0.44) TRPA1CYP2A6CYP1A2ALDH1A1NPC1
SCHEMBL11252558 0.75 TAAR1 (0.40) CYP2A6CYP1A2MAPTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4365180-A1 RARE EARTH COMPLEX Tosoh Corporation (JP) 2024-05-08 EP disclosed
CN-117616032-A Rare earth complex 东曹株式会社 2024-02-27 CN disclosed
WO-2023190472-A1 CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME 公益財団法人相模中央化学研究所 2023-10-05 WO disclosed
CN-111406059-B Europium complexes 东曹株式会社 2023-04-18 CN disclosed
WO-2023282236-A1 RARE EARTH COMPLEX 東ソー株式会社 2023-01-12 WO disclosed
US-20210340346-A1 METAL FILM-COATED MOLDED RESIN ARTICLES AND PRODUCTION METHOD THEREFOR MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) 2021-11-04 US disclosed
EP-3851553-A1 METAL-COATED MOLDED RESIN ARTICLES AND PRODUCTION METHOD THEREFOR Mitsubishi Engineering-Plastics Corporation (JP) 2021-07-21 EP disclosed
US-10988494-B2 Europium complex TOSOH CORPORATION (JP) 2021-04-27 US disclosed
CN-112654728-A Resin molded article with metal film and method for producing same 三菱工程塑料株式会社 2021-04-13 CN disclosed
US-20200354389-A1 EUROPIUM COMPLEX SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2020-11-12 US disclosed
US-20080051495-A1 Flame Retardant Resin Composition ASAHI KASEI CHEMICALS CORPORATION (JP) 2008-02-28 US disclosed
US-20070054084-A1 Optical recording medium and compound used for the same MITSUI CHEMICALS, INC. (JP) 2007-03-08 US disclosed
US-20070040154-A1 Flame retarder composition ASAHI KASEI CHEMICALS CORPORATION (JP) 2007-02-22 US disclosed
EP-1672626-A1 OPTICAL RECORDING MEDIUM AND COMPOUND USED IN THE OPTICAL RECORDING MEDIUM Mitsui Chemicals, Inc. (JP) 2006-06-21 EP disclosed
US-7060744-B2 Phosphazene composition ASAHI KASEI CHEMICALS CORPORATION (JP) 2006-06-13 US disclosed
US-20040039134-A1 Phosphazene composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2004-02-26 US disclosed
EP-0565488-B1 Fluorine free titanocenes and their application CIBA GEIGY AG (CH) 1999-04-21 EP disclosed
US-5340701-A Photoinitiators CIBA-GEIGY CORPORATION (US) 1994-08-23 US disclosed
EP-0590451-A1 Process for acylation of aromatic compounds BASF Aktiengesellschaft (DE) 1994-04-06 EP disclosed
EP-0565488-A1 Fluorine free titanocenes and their application CIBA-GEIGY AG (CH) 1993-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988494-B2 Europium complex SSB, XPA, UACA TRPA1 3213/4885CYP2A6 1000/4885CYP1A2 1130/4885
US-20200354389-A1 EUROPIUM COMPLEX SSB, XPA, UACA TRPA1 3213/4885CYP2A6 1000/4885CYP1A2 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.